The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vanguard Growth Index Fund

NYSE: VUG
Last

(U.S.) $135.39

Today's change+0.40 +0.30%
Updated October 20 8:00 PM -4GMT. Delayed by at least 15 minutes.
 

Vanguard Growth Index Fund

NYSE: VUG
Last

(U.S.) $135.39

Today's change+0.40 +0.30%
Updated October 20 8:00 PM -4GMT. Delayed by at least 15 minutes.

Vanguard Growth Index Fund Hits New 52-week High

Vanguard Growth Index Fund closed up Friday by (U.S.)$0.40 or 0.30% to (U.S.)$135.39 and setting a new 52-week high. Over the last five days, shares are unchanged, but have gained 21.45% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $135.57
  • Previous close(U.S.) $134.99
  • High(U.S.) $135.57
  • Low(U.S.) $135.21
  • Bid / Ask-- / --
  • YTD % change+21.45%
  • Volume466,230
  • Average volume (10-day)468,011
  • Average volume (1-month)482,244
  • Average volume (3-month)587,371
  • 52-week range(U.S.) $106.87 to (U.S.) $135.57
  • Beta1.07
  • Trailing P/E14.25×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.66
  • Dividend yield1.23%
  • Trailing EPS(U.S.) $9.50
Updated October 20 8:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+99.29%

Vanguard Growth Index Fund has a net profit margin of 99.29%. This is comparable to other companies in this industry group.
Company Books

S&P TSX0.25%Sector:FinancialsIndustry:Investment Trusts

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q4/2014Q2/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Dec 31, 201412/31/2014Jun 30, 201406/30/2014Dec 31, 201312/31/2013
Revenue5961,1299772,287
Total other revenue--------
Total revenue5961,1299772,287
Gross profit--------
Total cost of revenue--------
Total operating expense6765
Selling / general / administrative6765
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income5901,1239712,282
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5901,1239712,282
Income after tax5901,1239712,282
Income tax, total0----0
Net income5901,1239712,282
Total adjustments to net income--------
Net income before extra. items5901,1239712,282
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5901,1239712,282
Inc. avail. to common incl. extra. items5901,1239712,282
Diluted net income5901,1239712,282
Dilution adjustment--------
Diluted weighted average shares176183150137
Diluted EPS excluding extraordinary itemsvalue per share3.366.146.4916.63
Dividends per sharevalue per share0.630.710.550.63
Diluted normalized EPSvalue per share3.366.146.4916.63